Advertisement

Topics

Cytox Ltd Company Profile

22:16 EST 9th December 2018 | BioPortfolio


News Articles [10 Associated News Articles listed on BioPortfolio]

Cytox relaunches with £3.5m funding and Manchester base

A biomedical company is opening a new base in Manchester after securing a £3.5m funding package, including capital from the North West Fund.University of Birmingham spin-out Cytox has relaunched...

Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s

Cytox, a precision medicine company which today is commercializing polygenic risk scoring approaches for assessing genetic risk for developing Alzheimer's disease and other neurological diseases, has ...

Cytox raises £2.6m led by Catapult Ventures to launch predictive test for Alzheimer’s Disease

Alderley Park, UK – 14 June 2017. Cytox, a leader in genetic testing for Alzheimer’s Disease, today announced that it has raised £2.6m to fund the commercial launch and international...

Cytox sign up to ComplianceControl Centre

Cytox Limited, a UK company developing diagnostic and prognostic services for neurodegenerative diseases such as Alzheimer's disease, has signed up to the ComplianceControl Centre Electronic Quality...

Cytox Expands Collaboration with AIBL to Identify Those Most at Risk to Rapidly Progress to Alzheimer’s

Important research collaboration for pioneering PRS approach to help drug developers running clinical trials identify and stratify between slow and rapid progressors of the diseas...

Cytox Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryCytox Ltd Cytox is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company's blood tests are used to predict, which patients with MCI wi...

Cytox Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 16072018] Prices from USD $250

SummaryCytox Ltd Cytox is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of co...

Cytox Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 16052018] Prices from USD $250

SummaryCytox Ltd Cytox is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of co...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Cytox Limited

Cytox is a UK company developing products and services for neurodegenerative disorders. The company provides biomarker services to pharmaceutical industry clients conducting clinical trials with drugs...

Cytox Ltd

Cytox and Affymetrix

Affymetrix technologies enable multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of bench-top rese...

More Information about "Cytox Ltd" on BioPortfolio

We have published hundreds of Cytox Ltd news stories on BioPortfolio along with dozens of Cytox Ltd Clinical Trials and PubMed Articles about Cytox Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cytox Ltd Companies in our database. You can also find out about relevant Cytox Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record